Cyanokit expanded
October 14, 2010
THE European Commission has
approved a new presentation of
Merck Serono’s Cyanokit(R).
The new presentation contains
the starting dose of 5g
hydroxocobalamin in a single vial,
for the treatment of known or
suspected cyanide poisoning.
“Immediate administration of an
emergency treatment on the scene
of a fire within the first minutes
after rescue is critical for the
survival of a smoke inhalation
victim,” said Merck Serono’s
Executive Vice President Research
and Development, Dr. Bernhard
Kirschbaum.
“By simplifying the reconstitution
and administration processes, we
believe that the new Cyanokit 5 g
presentation represents a major
improvement, allowing for rapid
management of cyanide
poisoning, a vital asset particularly
when treating more than one
victim,” he added.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Oct 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Oct 10
